Conversely, the disruption of m7G modification resulting from METTL1 knockout leads to global translation defects of oncogenes and the loss of typical malignant transformation markers, thereby inhibiting the occurrence and development of intrahepatic cholangiocarcinoma (Dai et al., 2021). Here, METTL1 is linked to intrahepatic cholangiocarcinoma.